Following the completion of their business combination, Kinarus Therapeutics Holding AG and its wholly owned subsidiary Curatis Group AG have started a new strategic journey. Kinarus has rebranded itself to Curatis Holding AG. Curatis has become a publicly traded company under the name Curatis Group, based in Liestal, Basel. As of today, CURN.SW shares are trading on the SIX Swiss Exchange.
MORE
